Synthesis and structure-activity relationships of a series of novel benzopyran-containing platelet activating factor antagonists

Denise E. Guinn, James B. Summers, H. Robin Heyman, Richard G. Conway, David A. Rhein, Daniel H. Albert, Terry Magoc, George W. Carter

Journal of Medicinal Chemistry · 1992 · 22 citations · 0 references

DOIFull text

Open access

Concepts

Abstract

A class of N-substituted tetrahydrobenzopyrano[3,4-c]pyridines, I, have been identified as antagonists of platelet activating factor (PAF). The structural features essential for PAF binding were determined by systematic modification of three sites in the molecule. While O-alkyl analogues had little effect on binding potency, N-alkyl analogues exhibited a wide range of activity. Structural changes in the core ring system generally resulted in a loss of binding activity. Optimization of the N- and O-substituents resulted in the analogues 25-27 which exhibited Ki values ranging between 131 and 167 nM in a [3H]PAF binding assay. Compound 23 was also active in a model of PAF-induced shock in the mouse following intravenous administration.